As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...

Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for PT-141 ...

A team of researchers led by Professor Akitsu Hotta (Department of Clinical Application) developed a comprehensive framework ...

Large-scale data-management initiatives sit at the intersection of technical work and organizational change management.

Learn how viral vector release testing for AAV and lentiviral vectors utilizes orthogonal assays for titer, capsid content, ...

Discover how bioprocessing technology industrial applications expand as fermentation, membrane filtration, PAT, and ...

It started as a quiet experiment shared in a small community garden outside Portland, where gardeners were constantly looking ...

A quantitative approach for linking baseline sample size to statistics provides a statistically justified basis for ...

Conclusions The C-CAS, a self-report measure of coercive control experiences among women, has demonstrated initial reliability and validity and is suitable for use in population or clinical studies.

Dima Romashin, Founder and CEO of Efferon, is a healthcare entrepreneur who has spent the past decade building the company ...

The global CBD consumer health market was valued at $23.94 billion in 2025 and is projected to reach approximately $84.94 ...